newsfilter
← Latest News
GlobeNewswire·

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

NEW YORK and MELBOURNE, Australia, May 16, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), ("Incannex"), a clinical-stage biopharmaceutical company leading the way in developing oral combination